会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • MICRORNA ASSAY FOR DETECTION AND MANAGEMENT OF PANCREATIC CANCER PRECURSORS
    • MICRORNA测定胰腺癌前列腺癌的检测和治疗
    • WO2015153679A1
    • 2015-10-08
    • PCT/US2015/023702
    • 2015-03-31
    • H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
    • MALAFA, Mokenge, P.PERMUTH-WEY, JenniferCHEN, Dung-tsa
    • C12Q1/68C12N15/113C04B40/06
    • C12Q1/6886C12Q2600/118C12Q2600/158C12Q2600/178
    • The current invention pertains to miRNAs that are differentially expressed in samples of an individual having pancreatic cancer, or having a high risk of developing pancreatic cancer, as compared to the corresponding sample of an individual not having pancreatic cancer, or having low risk of developing pancreatic cancer, respectively. In certain embodiments, the miRNAs are differentially expressed in a tissue sample or blood plasma sample of an individual having a pancreatic lesion and having a high risk of developing pancreatic cancer as compared to the corresponding tissue sample or blood sample of an individual having the pancreatic lesion and having no risk or low risk of developing pancreatic cancer. These differentially expressed miRNAs can be used as biomarkers for diagnosis, treatment, and/or prevention of pancreatic cancer, particularly, in a subject having a pancreatic lesion. Microarray containing miRNAs indicative of the presence of pancreatic cancer, or having a high risk of pancreatic cancer development, particularly, in a subject having a pancreatic lesion, and methods of use of the microarrays are also provided.
    • 本发明涉及与没有胰腺癌的个体或具有低胰腺发展风险的相应样品相比,具有胰腺癌个体或具有发展胰腺癌的高风险的样品差异表达的miRNA 癌症。 在某些实施方案中,与具有胰腺病变的个体的相应组织样品或血液样品相比,miRNA在具有胰腺损伤并且具有发展胰腺癌的高风险的个体的组织样品或血浆样品中差异表达 并且没有发生胰腺癌的风险或低风险。 这些差异表达的miRNA可用作胰腺癌的诊断,治疗和/或预防的生物标志物,特别是在具有胰腺病变的受试者中。 还提供了含有指示胰腺癌存在或具有胰腺癌发展风险高的miRNA的微阵列,特别是在具有胰腺病变的受试者中,以及微阵列的使用方法。